LINDA DUNZIK: Open Payments
NPI 1316103872 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,027 in 43 payments from 21 companies in 2025. Trend: 2023 $3,047 · 2024 $3,756 · 2025 $1,027
Food & beverage: $847Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $194 |
| Novartis Pharmaceuticals Corporation | 9 | $168 |
| ABBVIE INC. | 3 | $79 |
| PFIZER INC. | 3 | $68 |
| Exact Sciences Corporation | 2 | $59 |
| Novo Nordisk Inc | 3 | $56 |
| Lilly USA, LLC | 3 | $50 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Astellas Pharma US Inc | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
Products named: ERLEADA, LEQVIO, The Cologuard Plus Collection Kit, IMBRUVICA, NURTEC ODT, OPDIVO, MOUNJARO, FRUZAQLA.
Industry payments across FL — which companies pay providers there.
